Androgen deprivation therapy use and duration with definitive radiotherapy for localised prostate cancer: an individual patient data meta-analysis

Overview of attention for article published in Lancet Oncology, January 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

So far, Altmetric has seen 123 X posts from 95 X users, with an upper bound of 299,383 followers.

@DrAndrewLoblaw @dr_coops We know from MARCAP https://t.co/4Ss9OQVcox that there is a large survival benefit to (a) adding ADT and (b) prolonging ADT. We know from SANDSTORM https://t.co/gZRVcpAnNx that ADT sequencing has a major impact too

RT @TylerSbrt: Request below for data supporting radical therapies for #prostatecancer ⬆️OS for RT: SPCG-7, NCIC PR07 (both RCTs) ⬆️OS fo…

Don’t forget @PCaParker Arm H if #STAMPEDE for RT to prostate in low volume mCPSC (and maybe @drdavidpalma #COMET for MDT of oligomets)

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 119 additional X posts.